Table 8.

Calculations and comparisons of gEUD values for 100 analyzed prostate treatments, 25 from each group (high‐, intermediate‐, low‐risk, and prostate bed patients)

			Prostate	Rectum	Bladder	R Fem Head	L Fem Head
HR	gEUD mean value (Gy)		$83.1\pm 0.5$	$57.2\pm 2.9$	$52.1\pm 3.0$	$27.5\pm 2.3$	$26.7\pm 2.4$
	Mean	M3D	$-1.0\pm 0.7$	$2.8\pm 2.0$	$-1.3\pm 0.8$	$1.9\pm 1.6$	$2.0\pm 1.7$
	difference (%)	CC	$-0.9\pm 0.4$	$0.1\pm 0.7$	$0.4\pm 0.6$	$3.2\pm 0.7$	$3.6\pm 0.7$
		CR	$-1.3\pm 0.7$	$3.2\pm 1.1$	$-1.3\pm 1.0$	$3.6\pm 1.0$	$3.1\pm 1.3$
	p‐values	M3D vs. CC	0.4	$<0.05$	$<0.05$	$<0.05$	$<0.05$
		M3D vs. CR	0.12	0.23	0.97	$<0.05$	$<0.05$
		CC vs. CR	$<0.05$	$<0.05$	$<0.05$	$<0.05$	0.07
IR	gEUD mean value (Gy)		$83.3\pm 0.6$	$57.3\pm 2.8$	$37.2\pm 6.8$	$21.8\pm 3.2$	$21.2\pm 3.0$
	Mean	M3D	$-0.1\pm 0.6$	$3.1\pm 1.6$	$-0.5\pm 1.4$	$1.6\pm 1.7$	$1.3\pm 1.1$
	difference (%)	CC	$-0.1\pm 0.3$	$0.3\pm 0.7$	$1.3\pm 0.7$	$2.4\pm 0.7$	$2.3\pm 0.8$
		CR	$0.1\pm 0.3$	$4.7\pm 1.3$	$-2.5\pm 1.3$	$4.2\pm 1.4$	$3.6\pm 1.1$
	p‐values	M3D vs. CC	0.53	$<0.05$	$<0.05$	$<0.05$	$<0.05$
		M3D vs. CR	0.12	$<0.05$	$<0.05$	$<0.05$	$<0.05$
		CC vs. CR	0.13	$<0.05$	$<0.05$	$<0.05$	$<0.05$
LR	gEUD mean value (Gy)		$83.2\pm 0.7$	$58.6\pm 2.4$	$37.0\pm 8.0$	$20.8\pm 2.8$	$20.7\pm 2.9$
	Mean	M3D	$-0.3\pm 0.7$	$3.4\pm 2.0$	$-0.3\pm 1.8$	$0.7\pm 1.2$	$0.7\pm 1.3$
	difference (%)	CC	$-0.1\pm 0.3$	$0.5\pm 0.7$	$1.4\pm 0.8$	$2.0\pm 0.6$	$2.0\pm 0.5$
		CR	$0.2\pm 0.5$	$4.7\pm 1.3$	$-1.9\pm 1.2$	$3.7\pm 0.9$	$2.9\pm 1.3$
	p‐values	M3D vs. CC	$<0.05$	$<0.05$	$<0.05$	$<0.05$	$<0.05$
		M3D vs. CR	$<0.05$	$<0.05$	$<0.05$	$<0.05$	$<0.05$
		CC vs. CR	$<0.05$	$<0.05$	$<0.05$	$<0.05$	$<0.05$
Bed	gEUD mean value (Gy)		$75.7\pm 0.5$	$58.8\pm 2.1$	$44.1\pm 5.9$	$23.2\pm 2.6$	$23.5\pm 3.1$
Mean	M3D	$-0.2\pm 0.9$	$3.1\pm 1.7$	$-1.3\pm 1.0$	$1.2\pm 1.2$	$1.2\pm 1.2$
	difference (%)	CC	$-0.3\pm 0.5$	$0.3\pm 0.9$	$0.4\pm 0.9$	$2.3\pm 0.6$	$2.2\pm 0.7$
		CR	$0.0\pm 0.5$	$3.7\pm 1.2$	$-1.2\pm 1.2$	$3.9\pm 1.3$	$3.7\pm 1.1$
	p‐values	M3D vs. CC	0.71	$<0.05$	$<0.05$	$<0.05$	$<0.05$
		M3D vs. CR	0.08	$<0.05$	0.75	$<0.05$	$<0.05$
		CC vs. CR	$<0.05$	$<0.05$	$<0.05$	$<0.05$	$<0.05$

$\mathrm{M}3\mathrm{D}=\text{Mobius}3\mathrm{D}$; $\text{CC}=\text{COMPASS dose calculation}$; $\text{CR}=\text{COMPASS dose reconstruction}$; $\text{HR}=\text{high}-\text{risk}$; $\text{IR}=\text{intermediate}-\text{risk}$; $\text{LR}=\text{low}-\text{risk}$.